Literature DB >> 21965549

Homozygosity mapping and exome sequencing reveal GATAD1 mutation in autosomal recessive dilated cardiomyopathy.

Jeanne L Theis1, Katharine M Sharpe, Martha E Matsumoto, High Seng Chai, Asha A Nair, Jason D Theis, Mariza de Andrade, Eric D Wieben, Virginia V Michels, Timothy M Olson.   

Abstract

BACKGROUND: Dilated cardiomyopathy (DCM) is a heritable, genetically heterogeneous disorder that typically exhibits autosomal dominant inheritance. Genomic strategies enable discovery of novel, unsuspected molecular underpinnings of familial DCM. We performed genome-wide mapping and exome sequencing in a unique family wherein DCM segregated as an autosomal recessive (AR) trait. METHODS AND
RESULTS: Echocardiography in 17 adult descendants of first cousins revealed DCM in 2 female siblings and idiopathic left ventricular enlargement in their brother. Genotyping and linkage analysis mapped an AR DCM locus to chromosome arm 7q21, which was validated and refined by high-density homozygosity mapping. Exome sequencing of the affected sisters was then used as a complementary strategy for mutation discovery. An iterative bioinformatics process was used to filter >40,000 genetic variants, revealing a single shared homozygous missense mutation localized to the 7q21 critical region. The mutation, absent in HapMap, 1000 Genomes, and 474 ethnically matched controls, altered a conserved residue of GATAD1, encoding GATA zinc finger domain-containing protein 1. Thirteen relatives were heterozygous mutation carriers with no evidence of myocardial disease, even at advanced ages. Immunohistochemistry demonstrated nuclear localization of GATAD1 in left ventricular myocytes, yet subcellular expression and nuclear morphology were aberrant in the proband.
CONCLUSIONS: Linkage analysis and exome sequencing were used as synergistic genomic strategies to identify GATAD1 as a gene for AR DCM. GATAD1 binds to a histone modification site that regulates gene expression. Consistent with murine DCM caused by genetic disruption of histone deacetylases, the data implicate an inherited basis for epigenetic dysregulation in human heart failure.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21965549      PMCID: PMC3248690          DOI: 10.1161/CIRCGENETICS.111.961052

Source DB:  PubMed          Journal:  Circ Cardiovasc Genet        ISSN: 1942-3268


  41 in total

1.  Mutations that alter the surface charge of alpha-tropomyosin are associated with dilated cardiomyopathy.

Authors:  T M Olson; N Y Kishimoto; F G Whitby; V V Michels
Journal:  J Mol Cell Cardiol       Date:  2001-04       Impact factor: 5.000

2.  Frequency of development of idiopathic dilated cardiomyopathy among relatives of patients with idiopathic dilated cardiomyopathy.

Authors:  Virginia V Michels; Timothy M Olson; Fletcher A Miller; Karla V Ballman; A Gabriela Rosales; David J Driscoll
Journal:  Am J Cardiol       Date:  2003-06-01       Impact factor: 2.778

3.  Mapping short DNA sequencing reads and calling variants using mapping quality scores.

Authors:  Heng Li; Jue Ruan; Richard Durbin
Journal:  Genome Res       Date:  2008-08-19       Impact factor: 9.043

4.  PennCNV: an integrated hidden Markov model designed for high-resolution copy number variation detection in whole-genome SNP genotyping data.

Authors:  Kai Wang; Mingyao Li; Dexter Hadley; Rui Liu; Joseph Glessner; Struan F A Grant; Hakon Hakonarson; Maja Bucan
Journal:  Genome Res       Date:  2007-10-05       Impact factor: 9.043

5.  Mutations in sarcomere protein genes as a cause of dilated cardiomyopathy.

Authors:  M Kamisago; S D Sharma; S R DePalma; S Solomon; P Sharma; B McDonough; L Smoot; M P Mullen; P K Woolf; E D Wigle; J G Seidman; C E Seidman
Journal:  N Engl J Med       Date:  2000-12-07       Impact factor: 91.245

6.  Genome-wide histone methylation profile for heart failure.

Authors:  Ruri Kaneda; Shuji Takada; Yoshihiro Yamashita; Young Lim Choi; Mutsuko Nonaka-Sarukawa; Manabu Soda; Yoshio Misawa; Tadashi Isomura; Kazuyuki Shimada; Hiroyuki Mano
Journal:  Genes Cells       Date:  2008-12-10       Impact factor: 1.891

7.  NCBI GEO: archive for high-throughput functional genomic data.

Authors:  Tanya Barrett; Dennis B Troup; Stephen E Wilhite; Pierre Ledoux; Dmitry Rudnev; Carlos Evangelista; Irene F Kim; Alexandra Soboleva; Maxim Tomashevsky; Kimberly A Marshall; Katherine H Phillippy; Patti M Sherman; Rolf N Muertter; Ron Edgar
Journal:  Nucleic Acids Res       Date:  2008-10-21       Impact factor: 16.971

8.  Defects in nuclear structure and function promote dilated cardiomyopathy in lamin A/C-deficient mice.

Authors:  Vesna Nikolova; Christiana Leimena; Aisling C McMahon; Ju Chiat Tan; Suchitra Chandar; Dilesh Jogia; Scott H Kesteven; Jan Michalicek; Robyn Otway; Fons Verheyen; Stephen Rainer; Colin L Stewart; David Martin; Michael P Feneley; Diane Fatkin
Journal:  J Clin Invest       Date:  2004-02       Impact factor: 14.808

9.  Burden of systolic and diastolic ventricular dysfunction in the community: appreciating the scope of the heart failure epidemic.

Authors:  Margaret M Redfield; Steven J Jacobsen; John C Burnett; Douglas W Mahoney; Kent R Bailey; Richard J Rodeheffer
Journal:  JAMA       Date:  2003-01-08       Impact factor: 56.272

10.  Fast and accurate short read alignment with Burrows-Wheeler transform.

Authors:  Heng Li; Richard Durbin
Journal:  Bioinformatics       Date:  2009-05-18       Impact factor: 6.937

View more
  36 in total

Review 1.  Genetic testing for inherited cardiac disease.

Authors:  Arthur A M Wilde; Elijah R Behr
Journal:  Nat Rev Cardiol       Date:  2013-07-30       Impact factor: 32.419

Review 2.  The promise of whole-exome sequencing in medical genetics.

Authors:  Bahareh Rabbani; Mustafa Tekin; Nejat Mahdieh
Journal:  J Hum Genet       Date:  2013-11-07       Impact factor: 3.172

Review 3.  Exome sequencing greatly expedites the progressive research of Mendelian diseases.

Authors:  Xuejun Zhang
Journal:  Front Med       Date:  2014-01-03       Impact factor: 4.592

4.  TNNI3K mutation in familial syndrome of conduction system disease, atrial tachyarrhythmia and dilated cardiomyopathy.

Authors:  Jeanne L Theis; Michael T Zimmermann; Brandon T Larsen; Inna N Rybakova; Pamela A Long; Jared M Evans; Sumit Middha; Mariza de Andrade; Richard L Moss; Eric D Wieben; Virginia V Michels; Timothy M Olson
Journal:  Hum Mol Genet       Date:  2014-06-11       Impact factor: 6.150

5.  Recessive TAF1A mutations reveal ribosomopathy in siblings with end-stage pediatric dilated cardiomyopathy.

Authors:  Pamela A Long; Jeanne L Theis; Yu-Huan Shih; Joseph J Maleszewski; Patrice C Abell Aleff; Jared M Evans; Xiaolei Xu; Timothy M Olson
Journal:  Hum Mol Genet       Date:  2017-08-01       Impact factor: 6.150

Review 6.  Next generation sequencing in cardiomyopathy: towards personalized genomics and medicine.

Authors:  Amitabh Biswas; V R Rao; Sandeep Seth; S K Maulik
Journal:  Mol Biol Rep       Date:  2014-08       Impact factor: 2.316

7.  Decreased expression and DNA methylation levels of GATAD1 in preeclamptic placentas.

Authors:  Xiaoling Ma; Jinping Li; Brian Brost; Wenjun Cheng; Shi-Wen Jiang
Journal:  Cell Signal       Date:  2014-01-22       Impact factor: 4.315

Review 8.  Genomics in cardiovascular disease.

Authors:  Robert Roberts; A J Marian; Sonny Dandona; Alexandre F R Stewart
Journal:  J Am Coll Cardiol       Date:  2013-03-21       Impact factor: 24.094

Review 9.  Genetics and genetic testing of dilated cardiomyopathy: a new perspective.

Authors:  Luisa Mestroni; Matthew R G Taylor
Journal:  Discov Med       Date:  2013-01       Impact factor: 2.970

Review 10.  Genetic evaluation of dilated cardiomyopathy.

Authors:  Ana Morales; Ray E Hershberger
Journal:  Curr Cardiol Rep       Date:  2013-07       Impact factor: 2.931

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.